Archives
- 2026-06
- 2026-05
- 2026-04
- 2026-03
- 2026-02
- 2026-01
- 2025-12
- 2025-11
- 2025-10
- 2025-09
- 2025-03
- 2025-02
- 2025-01
- 2024-12
- 2024-11
- 2024-10
- 2024-09
- 2024-08
- 2024-07
- 2024-06
- 2024-05
- 2024-04
- 2024-03
- 2024-02
- 2024-01
- 2023-12
- 2023-11
- 2023-10
- 2023-09
- 2023-08
- 2023-06
- 2023-05
- 2023-04
- 2023-03
- 2023-02
- 2023-01
- 2022-12
- 2022-11
- 2022-10
- 2022-09
- 2022-08
- 2022-07
- 2022-06
- 2022-05
- 2022-04
- 2022-03
- 2022-02
- 2022-01
- 2021-12
- 2021-11
- 2021-10
- 2021-09
- 2021-08
- 2021-07
- 2021-06
- 2021-05
- 2021-04
- 2021-03
- 2021-02
- 2021-01
- 2020-12
- 2020-11
- 2020-10
- 2020-09
- 2020-08
- 2020-07
- 2020-06
- 2020-05
- 2020-04
- 2020-03
- 2020-02
- 2020-01
- 2019-12
- 2019-11
- 2019-10
- 2019-09
- 2019-08
- 2018-07
-
25-Hydroxycholesterol Drives Immunosuppressive Macrophage Re
2026-06-17
Xiao et al. reveal that 25-hydroxycholesterol (25HC), produced via CH25H upregulation in tumor-associated macrophages (TAMs), accumulates in lysosomes and activates AMPKα, leading to STAT6-dependent immunosuppressive programming. This mechanistic insight positions CH25H as an immunometabolic checkpoint, with implications for re-educating TAMs and improving anti-tumor responses, particularly in combination with immune checkpoint blockade.
-
TRIB3 Knockdown Sensitizes ccRCC to Sunitinib via Ferroptosi
2026-06-17
This study demonstrates that silencing TRIB3 enhances the sensitivity of clear cell renal cell carcinoma (ccRCC) to Sunitinib by promoting ferroptosis through the SLC7A11/GPX4 pathway. The findings offer a mechanistic basis for overcoming Sunitinib resistance in ccRCC and suggest new research strategies for targeting ferroptotic cell death in resistant tumors.
-
Pulsed Plasma Degradation of Sulfamonomethoxine: Findings an
2026-06-16
This study demonstrates the effective degradation of sulfamonomethoxine (SMM) in aqueous solution using pulsed plasma discharge, revealing both the removal kinetics and the formation of transient by-products. The research highlights the environmental implications of plasma-generated hydrogen peroxide, emphasizing the need for further optimization to minimize ecotoxicity in water treatment applications.
-
ATRX-Deficient Glioma Cells: Sensitivity to RTK Inhibition
2026-06-16
The referenced study identifies that ATRX-deficient high-grade glioma cells display increased vulnerability to multi-targeted receptor tyrosine kinase (RTK) and PDGFR inhibitors. This mechanistic insight supports the strategic use of RTK inhibitors in ATRX-mutant glioma models, with implications for both preclinical research and clinical trial design.
-
Berberine Suppresses SASP Inflammation via RXRα/PPARγ/NEDD4
2026-06-15
This study reveals that berberine mitigates senescence-associated secretory phenotype (SASP)–driven inflammation in atherosclerosis by activating the RXRα/PPARγ/NEDD4 pathway in macrophage-derived foam cells. The research provides mechanistic clarity on how targeting this axis may offer new strategies for modulating chronic vascular inflammation and age-related cardiovascular disease.
-
Ferrostatin-1 (Fer-1) in Translational Ferroptosis Research
2026-06-15
Explore how Ferrostatin-1 (Fer-1) reshapes ferroptosis research, offering deep insights into oxidative lipid damage inhibition and advanced disease modeling. This article uniquely bridges mechanistic science and assay innovation, with practical takeaways for cancer and neurodegeneration studies.
-
Protease Inhibitor Cocktail EDTA-Free: Precision in Protein
2026-06-14
Preserve protein integrity in complex biological samples using APExBIO’s Protease Inhibitor Cocktail (EDTA-Free, 100X in DMSO). Unlock advanced workflows for phosphorylation-sensitive assays and troubleshoot common pitfalls with parameter-driven guidance.
-
Gingerenone A Reverses Sunitinib Resistance in Renal Cell Ca
2026-06-13
This study reveals that gingerenone A, a phenolic compound from ginger, inhibits LDHA-driven glycolysis and restores sunitinib sensitivity in renal cell carcinoma (RCC) models. The findings highlight a metabolic co-targeting strategy to overcome resistance to multi-targeted receptor tyrosine kinase inhibitors in RCC research.
-
GPR35-KLF5 Circuitry Directs Mucosal Repair in DSS Colitis M
2026-06-12
This study uncovers a tryptophan metabolic sensing mechanism in which GPR35 detects mucosal damage and activates KLF5-driven repair in intestinal epithelial cells. The findings clarify how epithelial cells decode injury signals, offering mechanistic insight for improving ulcerative colitis research and therapies using DSS-induced mouse models.
-
Live-Dead Cell Staining Kit: Reliable Viability for Modern L
2026-06-12
This article delivers a scenario-driven, evidence-based guide for researchers seeking reproducible and quantitative cell viability analysis. Grounded in real-world laboratory challenges, it demonstrates how the Live-Dead Cell Staining Kit (SKU K2081) from APExBIO empowers precise Calcein-AM Propidium Iodide staining for applications ranging from cytotoxicity testing to advanced biomaterials evaluation.
-
SLC11A1 Drives TGF-β1 Pathway to Resist Ferroptosis in CRC
2026-06-11
A recent study demonstrates that SLC11A1 overexpression activates the TGF-β1 signaling pathway, promoting resistance to ferroptosis and enhancing malignancy in colorectal cancer cells. These findings reveal SLC11A1 as a mechanistic driver of cell survival and a potential therapeutic target in colorectal cancer.
-
Ferrostatin-1 (Fer-1): Optimizing Ferroptosis Assays in Rese
2026-06-11
Ferrostatin-1 (Fer-1) enables precise modulation of ferroptosis in cancer biology and neurodegeneration models, acting as a nanomolar inhibitor of oxidative lipid damage. Explore advanced experimental workflows, troubleshooting insights, and the translational impact of Fer-1 in overcoming drug resistance and refining ferroptosis assays.
-
LY294002: Precision Control of PI3K Signaling and Synaptic M
2026-06-10
Explore LY294002, a potent PI3K/Akt/mTOR signaling pathway inhibitor, and its unique role in dissecting synaptic plasticity and cellular processes beyond conventional cancer research. This article provides advanced insights and practical assay guidance not found in existing resources.
-
HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus: Techni
2026-06-10
The HyperScribe™ T7 High Yield Cy3 RNA Labeling Kit Plus enables reliable, high-yield synthesis of randomly Cy3-labeled RNA probes for applications such as in situ hybridization and Northern blotting. It is designed for research workflows requiring sensitive fluorescent RNA detection, and is not validated for diagnostic or therapeutic use.
-
Cytochalasin D: Mechanistic Insights and Translational Front
2026-06-09
Explore Cytochalasin D as an actin polymerization inhibitor, uncovering its unique mechanisms of action, impact on cell cycle arrest, and advanced applications in cancer and viral research. This article provides an in-depth, evidence-backed analysis with fresh insights beyond standard protocols.